Design of Activatable NIR-II Molecular Probe for In Vivo Elucidation of Disease-Related Viscosity Variations

A clear elucidation of a disease-related viscosity change in vivo is significant yet highly challenging as well. Fluorescence imaging in the second near-infrared region (NIR-II, 1000–1700 nm) has gained increasing attention for observation in living organisms, but a viscosity-activatable fluorescent...

Full description

Saved in:
Bibliographic Details
Published inAnalytical chemistry (Washington) Vol. 92; no. 6; pp. 4177 - 4181
Main Authors Dou, Kun, Huang, Weijing, Xiang, Yunhui, Li, Songjiao, Liu, Zhihong
Format Journal Article
LanguageEnglish
Published United States American Chemical Society 17.03.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A clear elucidation of a disease-related viscosity change in vivo is significant yet highly challenging as well. Fluorescence imaging in the second near-infrared region (NIR-II, 1000–1700 nm) has gained increasing attention for observation in living organisms, but a viscosity-activatable fluorescent probe emitting at this region remains a vacancy. Herein, we report the first panel of a viscosity-activated NIR-II emissive fluorescent probe WD-X. By embedding different substituents into the WD-X platform and screening, we obtained an ideal probe, WD-NO 2 , which displayed the best combination of properties, including a 31-fold fluorescence enhancement in response to viscosity, insensitivity to environments (pH, polarity), and relatively high quantum yield (1.6% in glycerol). WD-NO 2 was successfully applied to track the variation of viscosity in diabetes-induced liver injury in vivo.
ISSN:0003-2700
1520-6882
DOI:10.1021/acs.analchem.0c00634